Department of Infectious Diseases, Hanoi Medical University, Hanoi, Vietnam.
Hanoi Medical University Hospital, Hanoi, Vietnam.
PLoS One. 2020 Oct 20;15(10):e0240830. doi: 10.1371/journal.pone.0240830. eCollection 2020.
Antimicrobial use is associated with emergence of antimicrobial resistance. We report hospital antimicrobial procurement, as a surrogate for consumption in humans, expenditure and prices in public hospitals in Vietnam, a lower middle-income country with a high burden of drug resistant infections.
Data on antimicrobial procurement were obtained from tender-winning bids from provincial health authorities and public hospitals with detailed bids representing 28.7% (1.68 / 5.85 billion US $) of total hospital medication spend in Vietnam. Antimicrobials were classified using the Anatomical Therapeutic Chemical (ATC) Index and the 2019 WHO Access, Watch, Reserve (AWaRe) groups. Volume was measured in number of Defined Daily Doses (DDD). Antimicrobial prices were presented per DDD.
Expenditure on systemic antibacterials and antifungals accounted for 28.6% (US $482.6 million/US $1.68 billion) of the total drug bids. 83% of antibacterials (572,698,014 DDDs) by volume (accounting for 45.5% of the antibacterials spend) were domestically supplied. Overall, the most procured antibacterials by DDD were second generation cephalosporins, combinations of penicillins and beta-lactamase inhibitors, and penicillins with extended spectrum. For parenteral antibacterials this was third generation cephalosporins. The average price for antibacterials was US $15.6, US $0.86, US $0.4 and US $11.7 per DDD for Reserve, Watch, Access and non-recommended/unclassified group antibacterials, respectively.
Antimicrobials accounted for a substantial proportion of the funds spent for medication in public hospitals in Vietnam. The pattern of antibacterial consumption was similar to other countries. The high prices of Reserve group and non-recommended/unclassified antibacterials suggests a need for a combination of national pricing and antimicrobial stewardship policies to ensure appropriate accessibility.
抗菌药物的使用与抗菌药物耐药性的出现有关。我们报告了越南公立医院的抗菌药物采购情况,这是人类抗菌药物消费的替代指标,还报告了越南公立医院的抗菌药物支出和价格,越南是一个中低收入国家,耐药感染负担沉重。
从省级卫生当局和公立医院的中标中获取抗菌药物采购数据,详细的中标代表了越南医院药物总支出的 28.7%(16.8 亿美元/58.5 亿美元)。抗菌药物使用解剖治疗化学(ATC)索引和 2019 年世界卫生组织(WHO)获取、监测、保留(AWaRe)分类进行分类。用量以每日限定剂量(DDD)的数量表示。抗菌药物价格以 DDD 表示。
全身抗菌药物和抗真菌药物支出占药物总投标的 28.6%(4.8269 亿美元/16.8 亿美元)。按体积(占抗菌药物支出的 45.5%)计算,83%的抗菌药物(572698014 个 DDD)为国产供应。总体而言,按 DDD 计算,采购量最大的抗菌药物是第二代头孢菌素、青霉素和β-内酰胺酶抑制剂组合以及具有广谱的青霉素。对于注射用抗菌药物,这是第三代头孢菌素。按 DDD 计算,抗菌药物的平均价格分别为 15.6 美元、0.86 美元、0.4 美元和 11.7 美元,分别为储备级、监测级、获取级和非推荐/未分类组抗菌药物。
抗菌药物在越南公立医院的药物支出中占相当大的比例。抗菌药物消费模式与其他国家相似。储备级和非推荐/未分类组抗菌药物的高价格表明需要结合国家定价和抗菌药物管理政策,以确保适当的可及性。